Cart
sales@molnova.com
Neurotensin
CAS No. 39379-15-2
Neurotensin( —— )
Catalog No. M30009 CAS No. 39379-15-2
Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 76 | In Stock |
|
| 5MG | 154 | In Stock |
|
| 10MG | 217 | In Stock |
|
| 25MG | 435 | In Stock |
|
| 50MG | 613 | In Stock |
|
| 100MG | 860 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNeurotensin
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
-
DescriptionNeurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorNeurotensin receptors (NTR)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number39379-15-2
-
Formula Weight1672.92
-
Molecular FormulaC78H121N21O20
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 33.33 mg/mL (19.92 mM)
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
2-Butenoic acid, 2-m...
Anti-osteoporosis agent-2 (Compound 10) is an anti-osteoporosis agent. Anti-osteoporosis agent-2 inhibits differentiation on osteoclast induced by RANKL.
-
Oxeladin citrate
Oxeladin is a cough suppressant. It is a highly potent and effective drug used to treat all types of cough of various etiologies.
-
4-IBP
4-IBP is a selective σ1 agonist with a high level of affinity for the σ1 receptor (Ki = 1.7 nM) and a moderate affinity for the σ2 receptor (Ki = 25.2 nM) .
